Background: Application of haptens to the skin induces release of immune stimulatory ATP into the extracellular space. This "danger" signal can be converted to immunosuppressive adenosine (ADO) by the action of the ectonucleotidases CD39 and CD73, expressed by skin and immune cells. Thus, the expression and regulation of CD73 by skin derived cells may have crucial influence on the outcome of contact hypersensitivity (CHS) reactions. Objective: To investigate the role of CD73 expression during 2,4,6-trinitrochlorobenzene (TNCB) induced CHS reactions. Methods: Wild type (wt) and CD73 deficient mice were subjected to TNCB induced CHS. In the different mouse strains the resulting ear swelling reaction was recorded along with a detailed phenotypic analysis of the skin migrating subsets of dendritic cells (DC). Results: In CD73 deficient animals the motility of DC was higher as compared to wt animals and in particular after sensitization we found increased migration of Langerin + DC from skin to draining lymph nodes (LN). In the TNCB model this led to a stronger sensitization as indicated by increased frequency of interferon-g producing T cells in the LN and an increased ear thickness after challenge. Conclusion: CD73 derived ADO production slows down migration of Langerin + DC from skin to LN. This may be a crucial mechanism to avoid over boarding immune reactions against haptens.
Introduction
Contact hypersensitivity (CHS), the murine model for allergic contact dermatitis in humans, can be induced by small (<1000 Da) chemical compounds (haptens). Upon penetration of the skin, haptens interact with proteins and develop into full antigens. The antigens are taken up by dendritic cells (DC) in the epidermis and dermis and are transported to peripheral lymph nodes (LN) [1] . Here priming and activation of T cells ensues. As activation of DC is necessary to enable DC migration from skin to draining LN, proinflammatory stimuli provided by TLR ligands and/or Adenosine triphosphate (ATP) are crucially involved in the induction of CHS reactions [2, 3] . Upon application of haptens ATP is released into the extracellular space in skin and LN either by pannexin channels in keratinocytes or by apoptotic cells [4, 5] . It serves as a potent "danger" signal [6] that provides the necessary stimulation of purine receptors and thus drives DC migration which normally follows sensitization. To compensate for this proinflammatory action, extracellular ATP in skin is degraded by the sequential action of the ectonucleotidases CD39 and CD73. CD39 converts extracellular ATP to ADP and AMP, respectively, and CD73 catalyses the dephosphorylation of these products into immunosuppressive adenosine (ADO) [7] [8] [9] [10] . Both molecules are expressed by skin cells such as keratinocytes and DC themselves. Accordingly, skin DC are able to detoxify the skin from proinflammatory ATP and may create a rather immune suppressive environment by means of ADO production. Therefore, regulation of ATP turnover during sensitization against haptens may modulate CHS reactions [11, 12] .
When subjecting CD73 deficient (CD73 À/À ) mice to a wellestablished TNCB-induced CHS protocol, we found in the present Abbreviations: ADO, adenosine; AR, ADO receptor; ATP, adenosine triphosphate; BMDC, bone marrow derived DC; CHS, contact hypersensitivity; DC, dendritic cells; d, day; FCS, fetal calf serum; IFN-g, interferon-g; IL, interleukin; LN, lymph node; TNCB, 2,4,6-trinitrochlorobenzene; wt, wild type.study increased ear swelling reactions that were not detectable in irritative eczema induced by croton oil. This indicates that a generalized hyperactivity of the skin immune system in CD73 À/À mice (due to a lack of ADO production) does not account for this effect. Further analysis revealed that deficiency of CD73 led to increased migration of CD207 + skin DC to draining LN, followed by enhanced priming of T cells. In aggregate, our data show a novel mechanism how turnover of ATP to ADO regulates motility of skin derived DC, affecting the sensitization phase of CHS reactions.
Materials and methods

Mice
C57BL/6 mice were purchased from Charles River (Sulzfeld, Germany), and CD73 deficient (CD73 À/À ) mice were from J.
Schrader. All mice were housed at the central animal facility of the University of Heidelberg cared for in accordance with the institutional guidelines for animal welfare.
Reagents and antibodies
Cell culture medium RPMI 1640 and supplements (Pen/Strep, HEPES, glutamine, FCS) were purchased from GE Healthcare (Freiburg, Germany). Minimal essential medium was from Thermo Fisher Scientific (Schwerte, Germany). Standard chemicals were purchased (if not stated otherwise) from Carl Roth (Karlsruhe, Germany). Adenosine, 8-(p-Sulfo-phenyl) theophylline, 5
0 -(Nethylcarboxamide) adenosine (NECA), 2,4,6-trinitro-1-chlorobenzene (TNCB), EDTA, Bovine Serumalbumin (BSA) were from SigmaAldrich (Taufkirchen, Germany). Monoclonal antibodies for flow cytometry were purchased from BD Biosciences (Heidelberg, Germany), from eBioscience (Frankfurt, Germany), from Biolegend (Fell, Germany) and from Santa Cruz Biotechnology (Santa Cruz, Heidelberg, Germany). The MicroBeads for the isolation of CD8 + T cells, CD11c + and MHCII + cells were purchased from Miltenyi Biotec (Bergisch Gladbach, Germany); FoxP3 staining set and 'Mouse FlowCytomix Basic Kit' were from eBioscience (Frankfurt, Germany).
CHS and irritant dermatitis
Mice were sensitized by painting 15 ml of 1% TNCB dissolved in acetone/olive oil (4:1) on the shaved abdomen on day 0. In some experiments mice were sensitized by subcutaneous injection of haptenized DC. Immature BMDC were haptenized with 10 nmol/l 2,4,6-trinitro-benzene-sulfonic acid (TNBS, Sigma-Aldrich) for 10 min at 37 C. The reaction was stopped by adding FCS for 1 min, followed by several washings with RPMI/10% FCS. On day 5 ear thickness was measured using microcalipers (Oditest, Kroeplin, Germany), followed by the epicutaneous application of 0.5% TNCB solution, 10 ml on each side of one ear. The other ear was treated with the same amount of solvent only. After 24 h, the ear thickness was measured again, and the difference was calculated as the change in ear response in mm Â 10 À2 AE SD. For adenosine and theophylline treatment, adenosine or theophylline were intradermally injected (20 ml of 10 mM solution) 90 min before sensitization. Irritant dermatitis was induced by application of 10 ml 0.8% croton oil in acetone on the ventral and dorsal side of the ear. Ear thickness was measured after 6 h and 12 h.
FACS analysis of skin migrating DC subsets
For isolation of skin migrating DC, draining LN were taken and cut into small pieces followed by a digestion for 1 h at 37 C in DMEM medium (BioWhittaker TM Lonza) supplemented with 10%
of FCS in the presence of 800 U/ml of Collagenase IV (Worthington) and 50 U/ml of DNase I (Sigma-Aldrich For intracellular staining cells were fixed and permeabilized using IC Fixation buffer and Permeabilization buffer (eBioscience). CD207 staining was performed for 35 min at RT with anti-CD207 Ab in the presence of TruStain fcX TM (anti-mouse CD16/32)
antibody. Samples were measured in Gallios flow cytometer (Beckman Coulter, Krefeld, Germany) and data were analyzed with FlowJo software v10.2 (TreeStar).
Preparation of BMDC and DC
Murine bone marrow-derived (BM) DC were prepared according to standard procedures [13] . In brief, bone marrow cells were cultured in RPMI 1640 supplemented with GM-CSF and IL-4 (Miltenyi Biotec; 10 ng/ml) for 6 d with intermittent feeding. Nonadherent cells were harvested and used for further experiments.
CD11c + cell were isolated from pooled lymph nodes (LN) and spleens of naive mice using the magnetic bead separation kit according to the manufacturer's protocol. After removal from the magnetic field, the CD11c + cells were eluted from the column and analyzed by FACS. The purity of the isolated cell populations ranged from 90 to 95%.
Analysis of mouse ears
Ear cells were obtained from mouse ear-halves by trypsinization for 30 min at 37 C. Isolated cells were analyzed by FACS. Thin tissue sections from mouse ears of the different experimental groups were saturated with 20% sucrose mounted in Tissue-Tek mounting-freezing media (Miles, Torrance, USA) and sectioned with a cryostat (Leica, Wetzlar, Germany). Sections were either stained with hematoxylin and eosin for morphologic evaluation or with fluorochrome-conjugated antibodies (Biolegend) for immunofluorescence analysis.
Crawl-out assay and migration studies
Ears were split, and dorsal halves were floated on medium containing 100 ng/ml rmCCL21 (Biolegend, Fell, Germany) for 3 d. Medium and chemokine were replaced daily. Migrated cells were stored at 4 C until the end of the assay, pooled and analyzed by FACS. Twenty-four-well format Boyden chambers (5-mm pore size) were purchased from Corning (Wiesbaden, Germany) and the lower compartments were filled with medium (600 ml) and CCL21
(100 ng/ml). A total of 1 Â10 6 crawl outs from the different mouse strains were placed into the upper compartments with or without ATP. After 2 h of incubation at 37 C migrated cells from the lower compartments were harvested, centrifuged and counted using a hemocyameter.
Intracellular cytokine staining and FlowCytomix
CD8
+ T cells isolated from the draining inguinal LNs of sensitized mice were stimulated with 2 ng/ml PMA und 0.4 mg/ ml Ionomycin. Next day Brefeldin A (10 ng/ml) was added to block cytokine secretion. Cells were surface stained with anti-CD8 and following permeabilization with anti-IFNg and measured by flow cytometer. FlowCytomix TM (eBioscience, Frankfurt) was used for simultaneous determinations of different cytokines using fluorescent latex beads coated with capture antibody. Analysis was performed according to the manufacturer's protocol.
Statistical analysis
Student t test (Graphpad Prism, Witzenhausen, Germany) was used as indicated in the figure legends.
Results
CD73
À/À mice show increased ear swelling in TNCB-induced CHS
To assess the effects of CD73 deficiency on inflammatory skin reactions, wild type (wt) and CD73 À/À mice were sensitized at the abdomen using a standard TNCB protocol. Animals were challenged after 5 d at the ear and ear swelling was measured 24 h later using a microcaliper. Fig. 1A shows increased ear swelling in CD73 À/À mice as compared to controls. These results were confirmed by immune histology, demonstrating a stronger infiltration of ear tissue by CD4 + T cells in CD73 À/À as compared to wt mice (Fig. 1B) .
To rule out that a generalized hyperresponsiveness of CD73 À/À mice to skin irritation accounts for this effect, we subjected mice to induction of an irritative eczema by applying croton oil to the ear skin. In these experiments comparable ear swelling reactions in wt and CD73 À/À mice were recorded (Fig. 1C) , indicating that CD73
À/À mice are not hyperreactive per se to skin-induced immune reactions. In line with this conclusion CD73 À/À mice showed similar frequencies of lymphocyte subpopulations in ear draining (cervical) lymph nodes (LN) (Fig. 1D ). However, a small but significant increase of MHC class II + cells is detectable in CD73
À/À mice, tempting us to speculate that antigen presentation is augmented in CD73 À/À in comparison to wt mice.
Ex vivo generated DC sensitize wt and CD73 À/À mice equally well
To test whether the sensitization phase or the elicitation phase accounts for the enhanced ear swelling reaction in CD73
À/À mice, we substituted the epicutaneous sensitization by injecting mice with different types of DC. We injected either ex vivo generated, haptenized bone marrow derived DC (BMDC) or haptenized DC isolated from LN. Mice were challenged at the ear 5d later. Fig. 1E shows that sensitization by injection of haptenized BMDC led to similar ear swelling reactions. Similar results were obtained when CD11c + LN DC isolated from donor mice were used for sensitization (data not shown). Thus, when circumventing topical application of the hapten and sensitizing solely with hapten pulsed DC, the ear swelling reaction after challenge is similar in wt and CD73 À/À mice.
Therefore we conclude that the challenging phase is not affected by CD73 deficiency, rather the cutaneous sensitization accounts for the enhanced ear swelling reaction in CD73 À/À mice. 
Enhanced activation of T cells in CD73 À/À mice
To investigate differences in the immunological reaction after sensitization between wt and CD73
À/À mice, we analyzed activation parameters of T cells in draining LN after applying a sensitizing dose of TNCB to the skin. As depicted in Fig. 2A were detected in CD73 À/À as compared to wt mice, indicating a more pronounced activation of T cells in absence of CD73. These results were further corroborated by cytokine data, indicating a significant increase in production of interferon-g (IFNg) by CD8 + T cells (Fig. 2B/C) as well as enhanced production of total IFNg and interleukin (IL)-4. Moreover, no difference in production of IL-2 was observed in CD73 À/À as compared to wt mice and the regulatory cytokine IL-10 was produced in comparable amounts as well (Fig. 2C) . Because IFNg is mandatory for effective priming of CD8 + T cells [14] , we conclude that a more effective sensitization occurs in CD73 À/À as compared to wt mice.
Enhanced migration of skin DC to LN in CD73 À/À mice
As activation of T cells in the sensitization phase of CHS reactions is critically dependent on skin migrating DC we next investigated the migration pattern of different defined skin DC subsets in wt and CD73
À/À mice in response to TNCB. After application of TNCB to the skin mice were sacrificed 1d, 2d and 3d later and skin draining LN were removed, followed by analysis of DC subsets by flow cytometry. (Fig. 3A) . Two to 3d after TNCB application significantly increased frequency and prolonged presence of CD207 + DC was detectable in LN of CD73 À/À animals as compared to wt controls (Fig. 3B) . Also the CD207 À CD11b + subset was significantly increased in CD73 À/ À animals at d2 after TNCB application. However, the CD11b À DC subset displayed no differences in frequencies in wt and CD73
À/À mice. Of note, we further observed upregulation of surface expression of CD73 in all skin migrating DC subsets in wt mice (Fig. 3C) , raising the possibility that ADO, which is autocrinely produced by migrating Langerhans cells is critically involved in regulating motility of these cells.
CD73
À/À skin cells crawl faster and migrate towards CCL21
To assess the migratory capacity of CD207 + skin migrating DC in response to haptens in vitro, we applied TNCB to both sides of the ears of wt and CD73 À/À animals. 1 h later ears were prepared and split in half. The dorsal sides were placed in 24 well dishes and cultivated with CCL21 for 1d-3d. Crawl outs were counted and analyzed accordingly. Here we found higher numbers of cells in the culture dishes containing ears of sensitized CD73 À/À animals as compared to wt ears (Fig. 4A) . 95% of all cells were MHC class II + + CD11c + , verifying their DC-identity (Fig. 4B) . Moreover, time lapse video microscopy revealed that crawl outs from CD73
À/À animals were more motile per se as compared to wtderived DC (Fig. 4C) . However, expression of activation markers such as CD80, CD86 and CD83 was similar in both mouse strains, indicating that different activation is not accountable for the different motility of the cells (Fig. 4B) . To mimick the proinflammatory situation of chemokine-induced recruitment of skin DC in vitro, crawl out DC from wt and CD73 À/À mice were placed into the upper compartments of boyden chambers + ATP, which serves as substrate for CD39/CD73. The medium in the bottom chamber was supplemented with 100 ng/ml CCL21. After 6 h increased migration of CD73 À/À -derived CD207 + skin cells in response to CCL21 was observed as compared to wt-derived cells (Fig. 4D ), corroborating our in vivo observation that expression of CD73 by skin DC is critical for regulating cell migration.
Intradermal application of ADO decreases ear swelling
To test whether application of ADO can substitute for activity of CD73, CD73 À/À animals were i.d. injected with ADO 1 h before sensitization. After 5d animals were challenged and ear swelling reaction was determined (Fig. 5) . In these experiments we show decreased ear swelling after treatment with ADO. Vice versa, we observed that pretreatment of wt mice with the ADO receptor antagonist Theophylline before sensitization increased the ear swelling as compared to controls. Thus, these data support our notion whereby ADO production by CD73 + skin DC is critical for slowing down DC migration to LN and consequently regulates the sensitization of T cells.
Discussion
The cellular components of the skin immune system and in particular skin residing DC are highly motile and can virtually be found in all remote skin areas of the body. For the induction of an immune response DC have to enter regional LN [16] . Thus, motility and directed migration is an integral part of their immune cell functions. Here we report that abrogating the function of the ectonucleotidase CD73 and consequently impeding the conversion of AMP and ADP to ADO, lead to increased migratory capacity of skin DC resulting in enhanced sensitization against haptens.
ADO, the product of the ectonucleotidase CD73, has well documented immunosuppressive functions as it downregulates the production of proinflammatory cytokines such as IL-1b and IL-12 by DC and monocytes [17] , suppresses antigen presentation [18] and shapes the polarization of T cells [19] [20] [21] . As far as migration of leukocytes is concerned, it has been shown that chemotaxis of neutrophils towards the chemoattractant peptide fMLP is mediated by adenosine [22, 23] . In support of these general immunosuppressive functions of ADO our results show that abrogation of CD73 activity, resulting in accumulation of extracellular ATP, leads to an increased CHS response. As underlying mechanism we found that expression of CD73 and ADO production thereof ameliorates the migration speed of skin DC. Activation markers in all DC subsets were unchanged, thus the different migration speed is most likely not due to a differential activation of wt and CD73 À/À skin DC.
In general purines such as ATP and ADO are able to exert effects on cell migration and cell positioning in tissues. For instance, microglia cells in the brain degrade ATP to ADO resulting in enhanced migration and outgrow into the central nervous tissue [24] . Moreover, endothelial cell migration and consequently angiogenesis is stimulated by ATP [25] and motility of breast and of lung cancer cells is regulated by ATP as well [26, 27] . Of note, these reports show that the initial purine that is released into the environment is ATP and not ADO. Only after ATP was converted to ADO by cell surface expressed ectonucleotidases such as CD39 and/ or CD73, a chemotactic activity was recorded. Thus, these data support our notion that by converting ATP to ADO in an autocrine fashion, cells can modulate speed and direction of migration [28, 29] .
It is known that purines such as ATP, which acts as substrate for CD39/CD73, may serve as a "find me" signal for leukocytes, because under non-inflammatory conditions extracellular ATP concentrations are kept low and only after necrotic cell death elevated ATP levels and substantial gradients of the metabolite ADO are present. Thus, once DC have reached an ATP-rich environment degradation of ATP to ADO helps firstly to detoxify proinflammatory acting ATP concentrations and secondly slows down migration of DC, which may be caused by autocrinely produced ADO. This may provide one mechanism as to how DC are kept at the side of inflammation as they are needed for clearance and detoxification of dying cells in peripheral tissues.
For changes in cell migration the cytoskeleton has to establish cytoplasmic protrusions into one direction and receptors as sensors have to be located here to direct the cell movement. As for adenosine, so far the receptors AR A3 [22, 30] and AR A2A [23] have been demonstrated to exhibit gradient-depend redistribution in the cell membranes and to give rise to directed migration of neutrophils. As to which ADO receptor (AR) is involved in mediating this altered migration of skin DC may so far only be deducted from results obtained with other DC subsets. For instance in immature human monocyte derived DC, ADO acts immunosuppressive as well as chemotactic by engaging G i -or G 0 -protein coupled AR A1 and AR A3 [31, 32] and the migratory response of plasmacytoid DC towards ADO is mediated by AR A1 [33, 34] . Thus, effects of ADO on DC migration may not only be attributed to one (out of four) particular AR, instead different expression pattern of AR may shape the reaction of cells towards ADO. However, as we and others [35, 36] have found strong expression of AR A2A and AR A3 in murine BMDC and observed altered migration in BMDC from AR A2A deficient mice but not in other AR knockout mice, it is conceivable that AR A2A may be involved in altering skin DC migration in response to ceased ADO production by CD73 À/À mice.
In aggregate our results point towards a novel mechanism as to how ADO regulates inflammatory reactions. In addition to well defined effects on effector functions of immune cells, our data demonstrate that the migration pattern of leukocytes from the periphery to secondary lymphoid organs can be modulated by ADO in the tissue environment, leading to an altered induction of immune responses.
